In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Precigen Inc’s stock clocked out at $3.86, down -3.98% from its previous closing price of $4.02. In other words, the price has decreased by -$3.98 from its previous closing price. On the day, 3.91 million shares were traded. PGEN stock price reached its highest trading level at $4.05 during the session, while it also had its lowest trading level at $3.77.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 30 ’25 when KINDLER JEFFREY B sold 106,837 shares for $3.38 per share. The transaction valued at 361,109 led to the insider holds 346,070 shares of the business.
KINDLER JEFFREY B sold 67,523 shares of PGEN for $243,083 on Sep 29 ’25. The Director now owns 452,907 shares after completing the transaction at $3.60 per share. On Sep 30 ’25, another insider, KIRK RANDAL J, who serves as the Director of the company, sold 1,809,667 shares for $3.41 each. As a result, the insider received 6,170,964 and left with 14,597,161 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 1362233856 and an Enterprise Value of 1126458496. For the stock, the TTM Price-to-Sale (P/S) ratio is 265.02. Its current Enterprise Value per Revenue stands at 259.553 whereas that against EBITDA is -12.263.
Stock Price History:
The Beta on a monthly basis for PGEN is 1.16, which has changed by 3.902439 over the last 52 weeks, in comparison to a change of 0.1476624 over the same period for the S&P500. Over the past 52 weeks, PGEN has reached a high of $5.22, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is 2.15%, while the 200-Day Moving Average is calculated to be 67.21%.
Shares Statistics:
It appears that PGEN traded 9.33M shares on average per day over the past three months and 3829470 shares per day over the past ten days. A total of 297.85M shares are outstanding, with a floating share count of 122.65M. Insiders hold about 58.84% of the company’s shares, while institutions hold 31.28% stake in the company. Shares short for PGEN as of 1761868800 were 34330841 with a Short Ratio of 3.68, compared to 1759190400 on 37754111. Therefore, it implies a Short% of Shares Outstanding of 34330841 and a Short% of Float of 15.07.
Earnings Estimates
The dynamic stock of Precigen Inc (PGEN) is currently being evaluated by a team of 2.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is -$0.03, with high estimates of -$0.03 and low estimates of -$0.03.
Analysts are recommending an EPS of between -$0.34 and -$0.44 for the fiscal current year, implying an average EPS of -$0.39. EPS for the following year is -$0.14, with 3.0 analysts recommending between -$0.02 and -$0.26.
Revenue Estimates
In. The current quarter, 2 analysts expect revenue to total $14.77M. It ranges from a high estimate of $15.34M to a low estimate of $14.2M. As of. The current estimate, Precigen Inc’s year-ago sales were $1.19MFor the next quarter, 2 analysts are estimating revenue of $24M. There is a high estimate of $24M for the next quarter, whereas the lowest estimate is $24M.
A total of 3 analysts have provided revenue estimates for PGEN’s current fiscal year. The highest revenue estimate was $17.53M, while the lowest revenue estimate was $2.34M, resulting in an average revenue estimate of $12.42M. In the same quarter a year ago, actual revenue was $3.92MBased on 3 analysts’ estimates, the company’s revenue will be $92.37M in the next fiscal year. The high estimate is $137.75M and the low estimate is $64M.
